N/A N=57 The Effect of Continuous Glucose Monitoring on Glycemic Control in Insulin-requiring Gestational Diabetes Mellitus
Gestational Diabetes Mellitus
Primary: Glycemic Control by Measurement of HbA1c — 5.17; 5.57 mean percentage
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=204 Convergence Insufficiency Treatment Study (CITS)
Convergence Insufficiency
Primary: Treatment Group Comparison of the Percentage of Participants Classified as an Overall Success at 12 Weeks - HB-C Versus HB-PU — 16; 15; 5 Participants — p=0.56
Phase 1 N=74 Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy Subjects
Healthy
Primary: Area Under the Concentration-time Curve of Linagliptin in Plasma Over the Time Interval From 0 to 72 Hours (AUC0-72) — 298.982; 307.320; 257.932; 261.680 nmol*h/L…
Phase 4 N=77 Use of Probiotics as Adjunctive Treatment for Chronic Rhinosinusitis
Chronic Rhinosinusitis
Primary: Mean Reduction in SNOT-20 Scores — 1.8; 5.5 units on a scale — p=0.23
Phase 3 N=49 Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth
Parkinson's Disease
Primary: Number of Subjects With Small Bowel Bacterial Overgrowth (SBBO) — 2; 12; 2; 9 participants — p=1.0
N/A N=44 Pedometers to Assess and Increase Physical Activity Among Children With Chronic Kidney Disease
Chronic Kidney Disease
Primary: Change in Physical Activity — 73; -133; 100 change in steps per day
Phase 3 N=710 Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)
Multiple Myeloma
Primary: Progression-Free Survival (PFS) — 46; 43; 33; 40 percentage of patients
Phase 2 N=29 Sitagliptin Umbilical Cord Blood Transplant Study
Leukemia, Myeloid, Acute · Acute Lymphoblastic Leukemia · Myelodysplasia
Primary: Cumulative Incidence of Patients With Engraftment by Day +30 Following Transplant — 88 percentage of participants
Phase 2 N=229 A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas
Basal Cell Carcinoma
Primary: Mean Percent Change From Baseline in the Number of Clinically Evident Basal Cell Carcinomas at Week 73 (After 72 Weeks of Treatment) — 62.9; 54.9 percent change
Phase 2 N=200 Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass
Acquired Antithrombin III Deficiency · Coronary Artery Bypass
Primary: Postoperative ATIII Levels at the ICU Admission — 94.06; 64.70 IU — p=<0.0001
Phase 1 N=16 A Study to Evaluate Effect of Itraconazole on the Pharmacokinetics of Cobimetinib in Healthy Participants
Healthy Participants
Primary: Maximum Observed Plasma Concentration (Cmax) of Cobimetinib With and Without Itraconazole — 5.21; 16.5 nanogram per milliliter (ng/mL)
Phase 2 N=63 Ovarian Cancer Vaccine for Patients in Remission
Epithelial Ovarian Cancer
Primary: Progression-free Survival — 12.89; 8.64 Months
N/A N=204 Tai Chi and Physical Therapy for Knee Osteoarthritis
Knee Osteoarthritis
Primary: Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC)Pain Subscale From Baseline to 12 Weeks — -167.2; -143 units on a scale
N/A N=83 Continuous Subpleural Infusion of Bupivacaine
Postoperative Pain
Primary: Number of Participants With and Without 30-Day Pain Medication Usage — 8; 6; 30; 36 participants
N/A N=73 Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a Prospective Randomized Controlled Trial
Endometriosis
Primary: Operative Time — 106.6; 101.6 minutes — p=0.71